Novel human enzymes and polynucleotides encoding the same

• US 20060063245A1
• Filed: 09/15/2005
• Published: 03/23/2006
• Est. Priority Date: 02/04/2000
• Status: Abandoned Application

• Current Assignee: Alejandro Abuin, Arthur T. Sands, Brian Zambrowicz, Glenn Friedrich, Nathaniel L. Wilganowski, Turner C. Alexander Jr, Walke D. Wade
• Original Assignee: Alejandro Abuin, Arthur T. Sands, Brian Zambrowicz, Glenn Friedrich, Nathaniel L. Wilganowski, Turner C. Alexander Jr, Walke D. Wade
• Inventors: Sands, Arthur T., Zambrowicz, Brian, Abuin, Alejandro, Wilganowski, Nathaniel L., Walke, D. Wade, Friedrich, Glenn, Turner, C. Alexander Jr.
• Application Number:
  US11/228,039
• Publication Number:
  US 20060063245A1
• Time in Patent Office: Days
• US Class Current: 435/183
• CPC Class Codes: C12N 9/1007 Methyltransferases (general) (2.1.1.)
• CPC Class Codes: C12N 9/1011 Catechol O-methyltransferase (2.1.1.6)

Abstract

Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.

Claims

1. An isolated nucleic acid molecule comprising at least 24 contiguous bases of nucleotide sequence first disclosed in SEQ ID NO:

1.

2. An isolated nucleic acid molecule comprising a nucleotide sequence that:

(a) encodes the amino acid sequence shown in SEQ ID NO;

2; and

(b) hybridizes under stringent conditions to the nucleotide sequence of SEQ ID NO;

1 or the complement thereof.

3. An isolated nucleic acid molecule encoding the amino acid sequence described in SEQ ID NO:

2.

4. An isolated oligopeptide comprising at least about 12 amino acids in a sequence first disclosed in SEQ ID NO:

2.

5. An isolated nucleic acid molecule encoding the amino acid sequence described in SEQ ID NO:

4.